47th ANNUAL NANOS MEETING
Sunday, February 21, 2021  8:00 am - 10:00 am
INFECTIOUS DISEASES IN NEURO-OPHTHALMOLOGY: IT'S NOT JUST COVID-19
Moderators: Jeffrey Bennett, MD, PhD and Beau Bruce, MD, PhD

Upon completion of this session, participants should be able to: (1) describe the features of multiple neuro-ophthalmic diseases caused by infectious agents, (2) describe management strategies that involve the use of immunosuppressive agents in the setting of known or possible infectious disease, and (3) describe national surveillance and bioterrorism preparedness for botulism.

Marc Dinkin, MD - COVID-19 and the Eye and Brain
  
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Lindsey De Lott, MD, MS - Immunosuppressive Therapy in the Setting of Infectious Risk

1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Lynn Gordon, MD, PhD - Infectious Optic Neuropathies: What Should I do Differently?

1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Guy Jirawuthiworavong, MD, MA - The Rise of Old Diseases: Syphilis and More

1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Beau Bruce, MD, PhD - Preparing for the Worst: Botulism - National Surveillance, Emergency Response, and Bioterrorism Preparedness

1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.





Overall Session Questions
1. Information presented by the speakers was relevant to my practice.


2. I will make changes in my practice as a result of what I learned from the speakers.


3. Did the speakers properly disclose their financial interests? (If no, please comment)




4. Were the presentations clear of commercial bias? (If no, please comment)




Did this program meet the stated learning objectives?





Sunday, February 21, 2021  10:15 am - 12:15 pm
JOURNAL CLUB: WHAT YOU NEED TO KNOW NOW!
Moderators:  Sophia Chung, MD and Kimberly Winges, MD

Upon completion of this session, participants should be able to: (1) define AI in neuro-ophthalmology, current use, and future impact to create algorithms and make clinical decisions from individual practices to global medicine, (2) discuss clinical applications of OCTA in neuro-ophthalmology, (3) Identify new advances in the diagnosis of optic disc drusen, (4) describe new immunotherapies in NMO, and (5) summarize and evaluate new medical and surgical treatments in IIH.

Anthony Arnold, MD - OCTA: What Can it Tell Me and How to Use It

1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Dan Milea, MD, PhD - AI in Neuro-Ophthalmology: What the Future Holds

1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Hiten A. Doshi, BS - Artifical Intelligence Reveals Disease Specific Quantifiable Visual Field Defects in Idiopathic Intracranial Hypertension

1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Jeffrey Bennett, MD, PhD - Newest Immunotherapies in NMO: Which One to Choose?
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Elena Solli, MD - Archetypal Analysis Identifies Quantifiable Visual Field Loss Patterns and Predictors of Recovery in Optic Neuritis
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Julie Falardeau, MD - Treatment of Intracranial Hypertension: New Options or Not?
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Prem S. Subramanian, MD, PhD - Effect of Prostaglandin Analogs on Cerebrospinal Fluid Reabsorption Via Nasal Mucosa
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.




Clare Fraser, FRANZCO - Optic Disc Drusen: Insights on Diagnosis
1. This speaker was a clear, effective speaker.


2. I have gained new knowledge from this presentation.


3. The teaching methods (format, Power Point slides and syllabus materials) were effective.





Overall Session Questions
1. Information presented by the speakers was relevant to my practice.


2. I will make changes in my practice as a result of what I learned from the speakers.


3. Did the speakers properly disclose their financial interests? (If no, please comment)




4. Were the presentations clear of commercial bias? (If no, please comment)




Did this program meet the stated learning objectives?